Latest News for PHYOF

Biogen Inc (NASDAQ:BIIB, XETRA:IDP) will acquire Apellis Pharmaceuticals Inc (NASDAQ:APLS) for $41 per share in cash, in a deal valued at approximately $5.6...

IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neurology imaging and data analytics specialist, is raising £10 million to fund a strategic push beyond its established contract research business, with Cavendish arguing the move could unlock a market opportunity up to ten times larger than the company currently addresses. The fundraise, structured as a conditional equity placing with a retail offer open to raise up to…

IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neuroscience imaging and analytics company, is raising up to £10.5 million through a combination of placings, a director subscription and a retail offer, as it seeks to accelerate development of its artificial intelligence-driven IXI platform and pursue US regulatory approval. The investment round comprises an initial placing of £2.8 million and a £0.1 million…

IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB) CEO Bram Goorden joined Proactive to discuss the company's new strategic collaboration with Medidata and its implications for growth. The partnership brings together IXICO's neuroimaging analytics with Medidata's global clinical trial platform.

IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB) CEO Bram Goorden joined Proactive to discuss the company’s new strategic collaboration with Medidata and its...
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for PHYOF.
Senate Trading
No Senate trades found for PHYOF.
U.S. House Trading
No House trades found for PHYOF.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
